Literature DB >> 18819929

Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces.

Daniel Rösel1, Jan Brábek, Ondrej Tolde, Claudia T Mierke, Daniel P Zitterbart, Carina Raupach, Krisýtyna Bicanová, Philip Kollmannsberger, Daniela Panková, Pavel Vesely, Petr Folk, Ben Fabry.   

Abstract

Tumor cell invasion is the most critical step of metastasis. Determination of the mode of invasion within the particular tumor is critical for effective cancer treatment. Protease-independent amoeboid mode of invasion has been described in carcinoma cells and more recently in sarcoma cells on treatment with protease inhibitors. To analyze invasive behavior, we compared highly metastatic sarcoma cells with parental nonmetastatic cells. The metastatic cells exhibited a functional up-regulation of Rho/ROCK signaling and, similarly to carcinoma cells, an amoeboid mode of invasion. Using confocal and traction force microscopy, we showed that an up-regulation of Rho/ROCK signaling leads to increased cytoskeletal dynamics, myosin light chain localization, and increased tractions at the leading edge of the cells and that all of these contributed to increased cell invasiveness in a three-dimensional collagen matrix. We conclude that cells of mesenchymal origin can use the amoeboid nonmesenchymal mode of invasion as their primary invading mechanism and show the dependence of ROCK-mediated amoeboid mode of invasion on the increased capacity of cells to generate force.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18819929     DOI: 10.1158/1541-7786.MCR-07-2174

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  44 in total

1.  The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.

Authors:  Vladimír Cermák; Jan Kosla; Jirí Plachý; Katerina Trejbalová; Jirí Hejnar; Michal Dvorák
Journal:  Cell Mol Life Sci       Date:  2010-05-28       Impact factor: 9.261

2.  Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells.

Authors:  Boon Tin Chua; Shu Jing Lim; Su Chin Tham; Wei Jie Poh; Axel Ullrich
Journal:  Mol Oncol       Date:  2010-03-19       Impact factor: 6.603

3.  Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion events.

Authors:  Amanda P Struckhoff; Jason R Vitko; Manish K Rana; Carter T Davis; Kamau E Foderingham; Chi-Hsin Liu; Lyndsay Vanhoy-Rhodes; Steven Elliot; Yun Zhu; Matt Burow; Rebecca A Worthylake
Journal:  J Cell Sci       Date:  2010-01-05       Impact factor: 5.285

4.  Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells.

Authors:  Lili Wang; Lexun Xue; Hongxia Yan; Jie Li; Yucheng Lu
Journal:  Mol Biol Rep       Date:  2009-08-02       Impact factor: 2.316

5.  Multiple roles for RhoA during T cell transendothelial migration.

Authors:  Sarah J Heasman; Anne J Ridley
Journal:  Small GTPases       Date:  2010-11

6.  Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces.

Authors:  Claudia Tanja Mierke; Benjamin Frey; Martina Fellner; Martin Herrmann; Ben Fabry
Journal:  J Cell Sci       Date:  2011-01-11       Impact factor: 5.285

7.  Cellular traction stresses mediate extracellular matrix degradation by invadopodia.

Authors:  Rachel J Jerrell; Aron Parekh
Journal:  Acta Biomater       Date:  2014-01-08       Impact factor: 8.947

8.  The role of the tissue microenvironment in the regulation of cancer cell motility and invasion.

Authors:  Jan Brábek; Claudia T Mierke; Daniel Rösel; Pavel Veselý; Ben Fabry
Journal:  Cell Commun Signal       Date:  2010-09-07       Impact factor: 5.712

9.  Mechanics rules cell biology.

Authors:  James Hc Wang; Bin Li
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2010-07-08

Review 10.  The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells.

Authors:  K Panková; D Rösel; M Novotný; Jan Brábek
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.